STOCK TITAN

Director at Winmark (WINA) receives 356 new stock options award

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Winmark Corp director Gina DeCaro Sprenger reported a new equity award. She received 356 Non-Employee Stock Options to buy Winmark common stock at an exercise price of $378.57 per share, vesting 25% per year for four years and expiring on June 1, 2036.

Following this filing, she directly holds 250 shares of common stock and multiple outstanding option grants, including one covering 10,000 underlying shares at an exercise price of $182.21 per share expiring on January 13, 2031. The transactions disclosed are compensation-related awards and holdings rather than open-market purchases or sales.

Positive

  • None.

Negative

  • None.
Insider SPRENGER GINA DECARO
Role null
Type Security Shares Price Value
Grant/Award Non-Employee Stock Option (right to buy) 356 $378.57 $135K
holding Non-Employee Stock Option (right to buy) -- -- --
holding Non-Employee Stock Option (right to buy) -- -- --
holding Non-Employee Stock Option (right to buy) -- -- --
holding Non-Employee Stock Option (right to buy) -- -- --
holding Non-Employee Stock Option (right to buy) -- -- --
holding Non-Employee Stock Option (right to buy) -- -- --
holding Non-Employee Stock Option (right to buy) -- -- --
holding Non-Employee Stock Option (right to buy) -- -- --
holding Non-Employee Stock Option (right to buy) -- -- --
holding Non-Employee Stock Option (right to buy) -- -- --
holding Non-Employee Stock Option (right to buy) -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Non-Employee Stock Option (right to buy) — 356 shares (Direct, null); Common Stock — 250 shares (Direct, null)
Footnotes (1)
  1. [object Object]
New option grant 356 options Non-Employee Stock Option grant on June 1, 2026
New grant exercise price $378.57 per share Exercise price for 356-option award
New grant expiration June 1, 2036 Expiration date of 356-option award
Common shares held 250 shares Direct common stock holding after transactions
Largest existing option 10,000 underlying shares Non-Employee Stock Option at $182.21, expiring January 13, 2031
Largest existing option exercise price $182.21 per share Exercise price for 10,000-share option grant
Non-Employee Stock Option (right to buy) financial
"security_title: "Non-Employee Stock Option (right to buy)""
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
exercise price financial
"conversion_or_exercise_price: "378.5700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"Footnote: "25% per year for four years.""
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SPRENGER GINA DECARO

(Last)(First)(Middle)
605 HIGHWAY 169 N
SUITE 400

(Street)
MINNEAPOLIS MINNESOTA 55441

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
WINMARK CORP [ WINA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock250D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Employee Stock Option (right to buy)$378.5706/01/2026A35606/01/2027(1)06/01/2036Common Stock356$378.57356D
Non-Employee Stock Option (right to buy)$182.2101/13/2022(1)01/13/2031Common Stock10,00010,000D
Non-Employee Stock Option (right to buy)$195.8206/01/2022(1)06/01/2031Common Stock750750D
Non-Employee Stock Option (right to buy)$261.3212/13/2022(1)12/13/2031Common Stock750750D
Non-Employee Stock Option (right to buy)$197.806/01/2023(1)06/01/2032Common Stock880880D
Non-Employee Stock Option (right to buy)$238.612/12/2023(1)12/12/2032Common Stock620620D
Non-Employee Stock Option (right to buy)$325.9906/01/2024(1)06/01/2033Common Stock380380D
Non-Employee Stock Option (right to buy)$446.6812/11/2024(1)12/11/2024Common Stock240240D
Non-Employee Stock Option (right to buy)$355.906/01/2025(1)06/01/2034Common Stock300300D
Non-Employee Stock Option (right to buy)$400.9712/09/2025(1)12/09/2034Common Stock300300D
Non-Employee Stock Option (right to buy)$424.8206/01/2026(1)06/01/2035Common Stock280280D
Non-Employee Stock Option (right to buy)$444.5412/15/2026(1)12/15/2035Common Stock256256D
Explanation of Responses:
1. 25% per year for four years.
/s/ Gina De Caro Sprenger06/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Winmark (WINA) director Gina DeCaro Sprenger report in this Form 4?

Gina DeCaro Sprenger reported a new grant of 356 Non-Employee Stock Options for Winmark common stock. These options are compensation-related awards, not open-market trades, and add to her existing stock and option holdings in the company.

How many new stock options did the Winmark (WINA) director receive and at what price?

She received 356 Non-Employee Stock Options with an exercise price of $378.57 per share. This means she can buy Winmark common stock at $378.57 if she exercises these options once they vest and before they expire.

When do Gina DeCaro Sprenger’s newly granted Winmark (WINA) options vest and expire?

The new 356-option grant vests 25% per year over four years and expires on June 1, 2036. Vesting gradually makes the options exercisable, while the expiration date is the last day she can exercise them.

How many Winmark (WINA) common shares does the director hold after this Form 4?

After the reported transactions, she directly holds 250 shares of Winmark common stock. This direct holding is in addition to her various outstanding stock option grants linked to Winmark common shares at different exercise prices and expiration dates.

What existing large Winmark (WINA) option position does the director report?

She reports an existing Non-Employee Stock Option covering 10,000 underlying Winmark common shares with a $182.21 exercise price, expiring January 13, 2031. This position reflects a substantial, previously granted equity incentive that remains outstanding.